Institutional
Lunate Holding RSC Ltd
CIK 0002009522
$210.9M
Reported AUM
4
Positions
Q4 2024
Period
2025-02-14
Filed
Editorial summary
Summary for Lunate Holding RSC Ltd · Q4 2024 is not yet generated. It will appear here after the next nightly run.
Portfolio · Q4 2024
Top holdings
| # | Stock | Issuer | Price | Day % | 1Y Gr. | 5Y Gr. | Value | % of book | Δ shares (QoQ) | Status |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | RVMD | REVOLUTION MEDICINES INC | $184.47 | 1.96% | 393.91% | 521.93% | $96.1M | 45.54% | — | HELD |
| 2 | BIRK | BIRKENSTOCK HOLDING PLC | $40.51 | -2.47% | -17.11% | -11.74% | $57.2M | 27.13% | — | HELD |
| 3 | LINE | LINEAGE INC | $44.42 | 0.18% | 11.08% | -41.94% | $35.1M | 16.66% | — | HELD |
| 4 | NMRA | NEUMORA THERAPEUTICS INC. | $1.63 | -1.21% | 5.77% | -84.89% | $22.5M | 10.67% | — | HELD |
Source: SEC EDGAR · accession 0001011438-25-000154. 13F discloses long positions only — shorts, foreign equities, and options are excluded.